Evidence map›Paper›PMID 35458200›Full record

Trial reportNutrients2022

Acute Effects of Kawakawa (

Farha Ramzan, Ramya Jayaprakash, Chris Pook, Meika Foster, Jennifer L Miles-Chan, Richard Mithen

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Review
  3. Anti-inflammatory effects of kawakawa (Food science & nutrition · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Farha RamzanLiggins Institute, The University of Auckland, 85 Park Road, Grafton, Private Bag 92019, Auckland 1142, New Zealand.ORCID 0000-0001-7590-1282
Ramya JayaprakashLiggins Institute, The University of Auckland, 85 Park Road, Grafton, Private Bag 92019, Auckland 1142, New Zealand.
Chris PookLiggins Institute, The University of Auckland, 85 Park Road, Grafton, Private Bag 92019, Auckland 1142, New Zealand.ORCID 0000-0002-0932-1965
Meika FosterLiggins Institute, The University of Auckland, 85 Park Road, Grafton, Private Bag 92019, Auckland 1142, New Zealand.
Jennifer L Miles-ChanHuman Nutrition Unit, School of Biological Sciences, The University of Auckland, Auckland 1024, New Zealand.ORCID 0000-0003-0313-7048
Richard MithenLiggins Institute, The University of Auckland, 85 Park Road, Grafton, Private Bag 92019, Auckland 1142, New Zealand.ORCID 0000-0001-7307-4324
University of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Piper excelsum (kawakawa) is an endemic shrub of Aotearoa, New Zealand, of cultural and medicinal importance to Māori. Its fruits and leaves are often consumed. These tissues contain several compounds that have been shown to be biologically active and which may underpin its putative health-promoting effects. The current study investigates whether kawakawa tea can modulate postprandial glucose metabolism. Methods: We report a pilot three-arm randomized crossover study to assess the bioavailability of kawakawa tea (BOKA-T) in six male participants with each arm having an acute intervention of kawakawa tea (4 g/250 mL water; 1 g/250 mL water; water) and a follow-up two-arm randomized crossover study to assess the impact of acute kawakawa tea ingestion on postprandial glucose metabolism in healthy human volunteers (TOAST) (4 g/250 mL water; and water; n = 30 (15 male and 15 female)). Participants consumed 250 mL of kawakawa tea or water control within each study prior to consuming a high-glycemic breakfast. Pre- and postprandial plasma glucose and insulin concentrations were measured, and the Matsuda index was calculated to measure insulin sensitivity. Results: In the BOKA-T study, lower plasma glucose (p < 0.01) and insulin (p < 0.01) concentrations at 60 min were observed after consumption of a high-dose kawakawa tea in comparison to low-dose or water. In the TOAST study, only plasma insulin (p = 0.01) was lower at 60 min in the high-dose kawakawa group compared to the control group. Both studies showed a trend towards higher insulin sensitivity in the high-dose kawakawa group compared to water only. Conclusions: Consuming kawakawa tea may modulate postprandial glucose metabolism. Further investigations with a longer-term intervention study are warranted.

Indexed as

Insulin ResistancePiperBlood GlucoseCross-Over StudiesFemaleHumansInsulinMalePostprandial PeriodTeaWaterBlood GlucoseInsulinTeaWaterinsulin sensitivitykawakawaMāori traditional medicineplasma insulinpostprandial

Identifiers

PMID35458200
PMCPMC9032225
OpenAlexW4224242935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.